Imunon, Inc. (IMNN)
Data as of , from SEC Form 4 filings.
See up to 3 months of IMNN. The 7-day demo opens the 1M and 3M ranges and puts IMNN on your watchlist.
Start 7-day demoLatest IMNN insider trades
Susan Eylward - OfficerOpen-market sale$4K- Susan Eylward - OfficerOpen-market sale$4K
About Imunon, Inc. (IMNN)
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.
- LAWRENCEVILLE, NJ
- 20
- 1995
- XNAS
IMNN Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 4 | 9,665 | $16K |
| Grant or award | 29 | 145,174 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
IMNN insider transactions (Form 4)
3459 Form 4 filings on record, the earliest from Oct 8, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Michael H. Tardugno - Officer | Grant or award | Common Stock | 7,800 footnote F1 | $1.08 | $8K | |
| ||||||
| Stacy Lindborg - Officer | Grant or award | Common Stock | 2,977 footnote F1 | $1.08 | $3K | |
| ||||||
| Douglas Vincent Faller - Officer | Grant or award | Common Stock | 1,249 footnote F1 | $1.08 | $1K | |
| ||||||
| Michael H. Tardugno - Officer | Grant or award | Common Stock | 7,169 footnote F1 | $1.41 | $10K | |
| ||||||
| Stacy Lindborg - Officer | Grant or award | Common Stock | 6,697 footnote F1 | $1.41 | $9K | |
| ||||||
| Douglas Vincent Faller - Officer | Grant or award | Common Stock | 4,390 footnote F1 | $1.41 | $6K | |
| ||||||
| Michael H. Tardugno - Officer | Grant or award | Common Stock | 5,824 footnote F1 | $1.47 | $9K | |
| ||||||
| Stacy Lindborg - Officer | Grant or award | Common Stock | 5,504 footnote F1 | $1.47 | $8K | |
| ||||||
| Douglas Vincent Faller - Officer | Grant or award | Common Stock | 4,211 footnote F1 | $1.47 | $6K | |
| ||||||
| Michael H. Tardugno - Officer | Grant or award | Common Stock | 7,371 footnote F1 | $1.60 | $12K | |
| ||||||
| Stacy Lindborg - Officer | Grant or award | Common Stock | 6,822 footnote F1 | $1.60 | $11K | |
| ||||||
| Douglas Vincent Faller - Officer | Grant or award | Common Stock | 3,626 footnote F1 | $1.60 | $6K | |
| ||||||
| Susan Eylward - Officer | Grant or award | Common Stock | 2,525 footnote F1 | $1.60 | $4K | |
| Susan Eylward - Officer | Open-market sale | Common Stock | 2,525 | $1.56 footnote F2 | $4K | |
| ||||||
| Stacy Lindborg - Officer | Grant or award | Common Stock | 6,615 footnote F1 | $1.65 | $11K | |
| ||||||
| Douglas Vincent Faller - Officer | Grant or award | Common Stock | 3,516 footnote F1 | $1.65 | $6K | |
| ||||||
| Michael H. Tardugno - Officer | Grant or award | Common Stock | 7,147 footnote F1 | $1.65 | $12K | |
| ||||||
| Susan Eylward - Officer | Grant or award | Common Stock | 2,449 footnote F1 | $1.65 | $4K | |
| Susan Eylward - Officer | Open-market sale | Common Stock | 2,449 | $1.63 footnote F2 | $4K | |
| ||||||
 Christine A. Pellizzari - Director | Grant or award | Common Stock | 6,934 footnote F1 | $1.59 | $11K | |
| ||||||
 James E. Dentzer - Director | Grant or award | Common Stock | 6,934 footnote F1 | $1.59 | $11K | |
| ||||||
| Frederick J. Fritz - Director | Grant or award | Common Stock | 6,934 footnote F1 | $1.59 | $11K | |
| ||||||
| Donald P. Braun - Director | Grant or award | Common Stock | 6,180 footnote F1 | $1.59 | $10K | |
| ||||||
| Susan Eylward - Officer | Grant or award | Common Stock | 2,541 footnote F1 | $1.59 | $4K | |
| Susan Eylward - Officer | Open-market sale | Common Stock | 2,541 | $1.57 footnote F2 | $4K | |
| ||||||
| Michael H. Tardugno - Officer | Grant or award | Common Stock | 6,358 footnote F1 | $1.59 | $10K | |
| ||||||
| Douglas Vincent Faller - Officer | Grant or award | Common Stock | 3,649 footnote F1 | $1.59 | $6K | |
| ||||||
| Stacy Lindborg - Officer | Grant or award | Common Stock | 5,010 footnote F1 | $1.59 | $8K | |
| ||||||
| Michael H. Tardugno - Officer | Grant or award | Common Stock | 4,603 footnote F1 | $1.83 | $8K | |
| ||||||
| Susan Eylward - Officer | Grant or award | Common Stock | 2,150 footnote F1 | $1.83 | $4K | |
| Susan Eylward - Officer | Open-market sale | Common Stock | 2,150 | $1.78 footnote F2 | $4K | |
| ||||||
| Douglas Vincent Faller - Officer | Grant or award | Common Stock | 3,082 footnote F1 | $1.83 | $6K | |
| ||||||
| Stacy Lindborg - Officer | Grant or award | Common Stock | 4,907 footnote F1 | $1.83 | $9K | |
| ||||||
| Michael H. Tardugno - Officer | Grant or award | Common Stock | 4,410 footnote F1 | $1.91 | $8K | |
| ||||||
Item 1.01, 3.02, 5.03, 9.01
Item 5.02
Item 2.02, 9.01
Item 5.02, 9.01
IMNN insider trading FAQ
What is the latest insider trade for IMNN?
Imunon, Inc. (IMNN) had 29 insider filings in the last 90 days, with the most recent on 2026-10-13. The full record for IMNN runs to 59 Form 4 filings, the earliest from 2024-10-08. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying IMNN stock?
No insider purchases of IMNN were filed in the last 90 days.
How many insiders are selling IMNN stock?
4 insider sales of IMNN were filed in the last 90 days, totaling $16K.
Where can I see IMNN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects IMNN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Michael H. Tardugno view on EDGAR
- - Stacy Lindborg view on EDGAR
- - Douglas Vincent Faller view on EDGAR
- - Michael H. Tardugno view on EDGAR
- - Stacy Lindborg view on EDGAR
- - Douglas Vincent Faller view on EDGAR
- - Michael H. Tardugno view on EDGAR
- - Stacy Lindborg view on EDGAR
- - Douglas Vincent Faller view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Insider activity in Health Care
- Where IMNN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow IMNN with a 7-day demo
- IMNN on your watchlist
- Every IMNN Form 4 filing on record
- Up to 3 months of IMNN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
